$LOAN
Manhattan Bridge Capital Inc Stock $loan

$loan Overview Financials Valuation SEC Filings Company Website

2014 Q1 Form 10-Q Financial Statement

#000114420414026724 Filed on May 01, 2014

Income Statement

Concept	2014 Q1	2013 Q1
Revenue	$608.9K	$534.4K
YoY Change	13.95%	37.02%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$180.0K	$170.0K
YoY Change	5.88%	0.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00	$0.00
YoY Change
% of Gross Profit
Operating Expenses	$170.0K	$180.0K
YoY Change	-5.56%	5.88%
Operating Profit	$316.4K	$258.3K
YoY Change	22.51%
Interest Expense	-$120.0K	-$100.0K
YoY Change	20.0%	150.0%
% of Operating Profit	-37.93%	-38.72%
Other Income/Expense, Net	$10.00K	$10.00K
YoY Change	0.0%	0.0%
Pretax Income	$323.3K	$265.1K
YoY Change	21.92%	39.55%
Income Tax	$115.0K	$92.00K
% Of Pretax Income	35.57%	34.7%
Net Earnings	$208.3K	$173.1K
YoY Change	20.29%	57.4%
Net Earnings / Revenue	34.2%	32.4%
Basic Earnings Per Share	$0.05	$0.04
Diluted Earnings Per Share	$0.05	$0.04
COMMON SHARES
Basic Shares Outstanding	4.256M shares	4.283M shares
Diluted Shares Outstanding	4.287M shares

Balance Sheet

Concept	2014 Q1	2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$0.00	$240.0K
YoY Change	-100.0%	500.0%
Cash & Equivalents	$931.00	$236.5K
Short-Term Investments
Other Short-Term Assets	$34.29K	$40.00K
YoY Change	-14.27%	-20.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$12.74M	$9.620M
YoY Change	32.44%	26.91%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$210.0K	$250.0K
YoY Change	-16.0%	0.0%
Other Assets	$17.50K	$40.00K
YoY Change	-56.25%	-42.86%
Total Long-Term Assets	$3.295M	$3.620M
YoY Change	-8.98%	26.13%
TOTAL ASSETS
Total Short-Term Assets	$12.74M	$9.620M
Total Long-Term Assets	$3.295M	$3.620M
Total Assets	$16.04M	$13.24M
YoY Change	21.11%	26.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$20.00K	$60.00K
YoY Change	-66.67%	-14.29%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$1.319M	$1.160M
YoY Change	13.75%	-18.31%
Long-Term Debt Due	$5.300M	$3.200M
YoY Change	65.63%
Total Short-Term Liabilities	$6.974M	$4.620M
YoY Change	50.95%	164.0%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.974M	$4.620M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$6.970M	$4.620M
YoY Change	50.87%	105.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$322.0K
YoY Change
Common Stock	$9.753M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$369.3K
YoY Change
Treasury Stock Shares	177.0K shares
Shareholders Equity	$9.062M	$8.620M
YoY Change
Total Liabilities & Shareholders Equity	$16.04M	$13.24M
YoY Change	21.11%	26.7%

Cashflow Statement

Concept	2014 Q1	2013 Q1
OPERATING ACTIVITIES
Net Income	$208.3K	$173.1K
YoY Change	20.29%	57.4%
Depreciation, Depletion And Amortization	$0.00	$0.00
YoY Change
Cash From Operating Activities	-$30.00K	-$20.00K
YoY Change	50.0%	-128.57%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$880.0K	$1.090M
YoY Change	-180.73%	-309.62%
Cash From Investing Activities	-$880.0K	$1.090M
YoY Change	-180.73%	-309.62%
FINANCING ACTIVITIES
Cash Dividend Paid	$42.56K	$0.00
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-110.0K	-1.070M
YoY Change	-89.72%	-496.3%
NET CHANGE
Cash From Operating Activities	-30.00K	-20.00K
Cash From Investing Activities	-880.0K	1.090M
Cash From Financing Activities	-110.0K	-1.070M
Net Change In Cash	-1.020M	0.000
YoY Change		-100.0%
FREE CASH FLOW
Cash From Operating Activities	-$30.00K	-$20.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	loan	Long Term Loans Receivable LongTermLoansReceivable	3997000	USD
CY2014Q1	loan	Long Term Loans Receivable LongTermLoansReceivable	3058950	USD
CY2014Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	17468	USD
CY2013Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	57066	USD
CY2014Q1	loan	Deferred Origination Fees DeferredOriginationFees	123512	USD
CY2013Q4	loan	Deferred Origination Fees DeferredOriginationFees	132017	USD
CY2014Q1	us-gaap	Common Stock Value CommonStockValue	4433	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	4433	USD
CY2014Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	9748664	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	9745249	USD
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	369335	USD
CY2014Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-321952	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-487660	USD
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	9061810	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	8892687	USD
CY2014Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16035479	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16124454	USD
CY2013Q1	us-gaap	Loans And Leases Receivable Gross Carrying Amount Commercial LoansAndLeasesReceivableGrossCarryingAmountCommercial	12534000	USD
CY2014Q1	us-gaap	Loans And Leases Receivable Gross Carrying Amount Commercial LoansAndLeasesReceivableGrossCarryingAmountCommercial	15575950	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q1	us-gaap	Treasury Stock Value TreasuryStockValue	369335	USD
CY2014Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	931	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1021023	USD
CY2014Q1	loan	Short Term Loans Receivable ShortTermLoansReceivable	12517000	USD
CY2013Q4	loan	Short Term Loans Receivable ShortTermLoansReceivable	10697950	USD
CY2014Q1	us-gaap	Interest Receivable Current InterestReceivableCurrent	188348	USD
CY2013Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	171483	USD
CY2014Q1	us-gaap	Other Assets Current OtherAssetsCurrent	34292	USD
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	18540	USD
CY2014Q1	us-gaap	Assets Current AssetsCurrent	12740571	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	11908996	USD
CY2014Q1	loan	Investment In Real Estate InvestmentInRealEstate	146821	USD
CY2013Q4	loan	Investment In Real Estate InvestmentInRealEstate	146821	USD
CY2014Q1	us-gaap	Security Deposit SecurityDeposit	6637	USD
CY2013Q4	us-gaap	Security Deposit SecurityDeposit	6637	USD
CY2014Q1	us-gaap	Cost Method Investments CostMethodInvestments	65000	USD
CY2013Q4	us-gaap	Cost Method Investments CostMethodInvestments	65000	USD
CY2014Q1	us-gaap	Assets Assets	16035479	USD
CY2013Q4	us-gaap	Assets Assets	16124454	USD
CY2014Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	1319465	USD
CY2013Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1319465	USD
CY2014Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	5300000	USD
CY2013Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	5350000	USD
CY2014Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	213224	USD
CY2013Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	373219	USD
CY2014Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6973669	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7231767	USD
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0107	pure
CY2014Q1	loan	Additional Construction Loan For Borrowers Subject To Conditions AdditionalConstructionLoanForBorrowersSubjectToConditions	1035500	USD
CY2014Q1	loan	Commercial Loans Issued To Borrowers CommercialLoansIssuedToBorrowers	3343950	USD
CY2014Q1	loan	Aggregate Percentage Of Commercial Loans Issued AggregatePercentageOfCommercialLoansIssued	0.215	pure
CY2014Q1	loan	Jointly Funded Loans Total JointlyFundedLoansTotal	1625000	USD
CY2014Q1	loan	Jointly Funded Loans JointlyFundedLoans	1125000	USD
CY2011Q1	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings	675000	USD
CY2011Q1	loan	Option Sold OptionSold	3900	USD
CY2011Q1	loan	Option Monthly Fee OptionMonthlyFee	10530	USD
CY2014Q1	loan	Exercise Price Of Remaining Property ExercisePriceOfRemainingProperty	146821	USD
CY2014Q1	loan	Monthly Option Fee For Property After Partial Exercise Of Option MonthlyOptionFeeForPropertyAfterPartialExerciseOfOption	2296	USD
CY2014Q1	loan	Property Selling Price PropertySellingPrice	410000	USD
CY2013Q1	loan	Fees Generated From Seller Buy Back Options FeesGeneratedFromSellerBuyBackOptions	6887	USD
CY2014Q1	loan	Fees Generated From Seller Buy Back Options FeesGeneratedFromSellerBuyBackOptions	6887	USD
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4283218	shares
CY2013Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	12440	shares
CY2014Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	30483	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	285000	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2014Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	140000	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	145000	shares
CY2014Q1	loan	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableNumber	143000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.97
CY2014Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2014Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.74
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.20
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	1.20
CY2014Q1	loan	Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term Outstanding Option ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermOutstandingOption	P2Y3M22D
CY2014Q1	loan	Share Based Compensation Arrangement By Share Based Payment Award Option Weighted Average Remaining Contractual Term For Vested And Exercisable Options ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionWeightedAverageRemainingContractualTermForVestedAndExercisableOptions	P2Y3M22D
CY2014Q1	loan	Share Based Compensation Arrangement By Share Based Payment Award Vested And Non Vested Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndNonVestedOptionsOutstandingIntrinsicValue	100082	USD
CY2014Q1	loan	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableAggregateIntrinsicValue	98884	USD
CY2013Q1	loan	Share Based Compensation Expense ShareBasedCompensationExpense	3416	USD
CY2014Q1	loan	Share Based Compensation Expense ShareBasedCompensationExpense	3416	USD
CY2014Q1	loan	Amortization Of Fair Value AmortizationOfFairValue	P15Y
CY2014Q1	loan	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights For Employee And Nonemployee Directors SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsForEmployeeAndNonemployeeDirectors	The options may vest over a period not to exceed ten years. Stock options under our stock option plan may be awarded to officers, key-employees, consultants and non-employee directors of the Company. Under our stock option plan, every non-employee director of the Company is granted 7,000 options upon first taking office, and then 7,000 upon each additional year in office.
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0261	pure
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.75	pure
CY2014Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2014Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2014Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4433190	shares
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4286673	shares
CY2013Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	262560	shares
CY2014Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	112517	shares
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-110062	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4180	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1020092	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	240693	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	236513	USD
CY2013Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	274120	USD
CY2014Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	274995	USD
CY2013Q1	us-gaap	Interest Paid InterestPaid	89541	USD
CY2014Q1	us-gaap	Interest Paid InterestPaid	116423	USD
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4433190	shares
CY2014Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4256190	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4256190	shares
CY2014Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	177000	shares
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	177000	shares
CY2011	loan	Operating Lease Term Of Lease OperatingLeaseTermOfLease	five years and two months
CY2013Q1	loan	Interest Income From Loans InterestIncomeFromLoans	444779	USD
CY2014Q1	loan	Interest Income From Loans InterestIncomeFromLoans	507371	USD
CY2013Q1	loan	Origination Fees OriginationFees	89582	USD
CY2014Q1	loan	Origination Fees OriginationFees	101539	USD
CY2013Q1	us-gaap	Revenues Revenues	534361	USD
CY2014Q1	us-gaap	Revenues Revenues	608910	USD
CY2013Q1	loan	Interest And Amortization Of Debt Service Costs InterestAndAmortizationOfDebtServiceCosts	102646	USD
CY2014Q1	loan	Interest And Amortization Of Debt Service Costs InterestAndAmortizationOfDebtServiceCosts	116423	USD
CY2013Q1	loan	Referral Fees ReferralFees	596	USD
CY2014Q1	loan	Referral Fees ReferralFees	109	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	172867	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	175996	USD
CY2013Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	276109	USD
CY2014Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	292528	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	258252	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	316382	USD
CY2013Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	6887	USD
CY2014Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	6887	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	265139	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	323269	USD
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	92000	USD
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	115000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	173139	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	208269	USD
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2013Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	13104	USD
CY2014Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3416	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3416	USD
CY2013Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-12689	USD
CY2014Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	16865	USD
CY2013Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	22658	USD
CY2014Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	15752	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-12773	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-39599	USD
CY2013Q1	loan	Increase Decrease In Deferred Origination Fees IncreaseDecreaseInDeferredOriginationFees	6209	USD
CY2014Q1	loan	Increase Decrease In Deferred Origination Fees IncreaseDecreaseInDeferredOriginationFees	8504	USD
CY2013Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-182120	USD
CY2014Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-159995	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-21412	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-29030	USD
CY2013Q1	loan	Issuance Of Short Term Loans IssuanceOfShortTermLoans	2853500	USD
CY2014Q1	loan	Issuance Of Short Term Loans IssuanceOfShortTermLoans	4774000	USD
CY2013Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	3943866	USD
CY2014Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	3893000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	1090366	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-881000	USD
CY2013Q1	loan	Proceeds From Loans And Line Of Credit ProceedsFromLoansAndLineOfCredit	-1040000	USD
CY2014Q1	loan	Proceeds From Loans And Line Of Credit ProceedsFromLoansAndLineOfCredit	-50000	USD
CY2013Q1	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	37824	USD
CY2014Q1	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	0	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	4690	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	0	USD
CY2013Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
CY2014Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	42562	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-1073134	USD
CY2014Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	17500	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	0	USD
CY2013Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2014Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	17500	USD
CY2014Q1	dei	Document Type DocumentType	10-Q
CY2014Q1	dei	Amendment Flag AmendmentFlag	false
CY2014Q1	dei	Document Period End Date DocumentPeriodEndDate	2014-03-31
CY2014Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2014Q1	dei	Trading Symbol TradingSymbol	LOAN
CY2014Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4270190	shares
CY2014Q1	dei	Entity Registrant Name EntityRegistrantName	MANHATTAN BRIDGE CAPITAL, INC
CY2014Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001080340
CY2014Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014Q1	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company

Files In Submission

Name	View Source	Status
0001144204-14-026724-index-headers.html	Edgar Link	pending
0001144204-14-026724-index.html	Edgar Link	pending
0001144204-14-026724.txt	Edgar Link	pending
0001144204-14-026724-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
loan-20140331.xml	Edgar Link	completed
loan-20140331.xsd	Edgar Link	pending
loan-20140331_cal.xml	Edgar Link	unprocessable
loan-20140331_def.xml	Edgar Link	unprocessable
loan-20140331_lab.xml	Edgar Link	unprocessable
loan-20140331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v375846_10q.htm	Edgar Link	pending
v375846_ex31-1.htm	Edgar Link	pending
v375846_ex31-2.htm	Edgar Link	pending
v375846_ex32-1.htm	Edgar Link	pending
v375846_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LOAN
Manhattan Bridge Capital Inc Stock $loan

2014 Q1 Form 10-Q Financial Statement

#000114420414026724 Filed on May 01, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LOAN Manhattan Bridge Capital Inc Stock $loan

2014 Q1 Form 10-Q Financial Statement

#000114420414026724 Filed on May 01, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LOAN
Manhattan Bridge Capital Inc Stock $loan